Source: China – South China Morning PostA Taiwanese vaccine developer said it would release phase 2 clinical trial data on Thursday, as the island continues to grapple with an outbreak of the coronavirus.The island’s Central Epidemic Command Centre reported 263 new local cases of Covid-19, three imported case and 28 deaths.Medigen Vaccine Biologics said it would announce the results of a phase 2 trial later on Thursday and apply to the Food and Drug Administration for emergency use authorisation, according to local media reports…Read More